Stock News

Signature Estate & Investment Advisors Has Boosted By $810,546 Its Carnival (CCL) Holding; Adamis Pharmaceuticals (ADMP) Shorts Decreased By 1.49%

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Logo

Signature Estate & Investment Advisors Llc increased Carnival Corp (CCL) stake by 4.98% reported in 2017Q4 SEC filing. Signature Estate & Investment Advisors Llc acquired 12,281 shares as Carnival Corp (CCL)’s stock declined 0.93%. The Signature Estate & Investment Advisors Llc holds 259,085 shares with $17.20M value, up from 246,804 last quarter. Carnival Corp now has $46.52B valuation. The stock decreased 0.49% or $0.32 during the last trading session, reaching $65.14. About 409,039 shares traded. Carnival Corporation (NYSE:CCL) has risen 11.65% since May 17, 2017 and is uptrending. It has outperformed by 0.10% the S&P500.

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) had a decrease of 1.49% in short interest. ADMP’s SI was 3.39M shares in May as released by FINRA. Its down 1.49% from 3.45 million shares previously. With 496,400 avg volume, 7 days are for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)’s short sellers to cover ADMP’s short positions. The SI to Adamis Pharmaceuticals Corporation’s float is 11.61%. The stock increased 1.84% or $0.08 during the last trading session, reaching $4.15. About 141,378 shares traded. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) has declined 20.00% since May 17, 2017 and is downtrending. It has underperformed by 31.55% the S&P500.

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.11, from 1.11 in 2017Q3. It is positive, as 47 investors sold CCL shares while 217 reduced holdings. 78 funds opened positions while 243 raised stakes. 398.04 million shares or 0.19% less from 398.79 million shares in 2017Q3 were reported. Schwab Charles Invest Mngmt Inc owns 1.58 million shares for 0.08% of their portfolio. Evercore Wealth Mngmt Ltd Liability Corp holds 0% in Carnival Corporation (NYSE:CCL) or 300 shares. Chemical Comml Bank holds 26,480 shares. Fmr Limited holds 0.02% or 2.13M shares. Cetera Advsrs Limited Liability Corporation holds 4,977 shares. Moreover, M&T Bancorp has 0.03% invested in Carnival Corporation (NYSE:CCL). Meag Munich Ergo Kapitalanlagegesellschaft Mbh, Germany-based fund reported 52,394 shares. Whittier Tru reported 145 shares. Capital Interest Inc Ca has 0.11% invested in Carnival Corporation (NYSE:CCL). Willingdon Wealth Management owns 0.33% invested in Carnival Corporation (NYSE:CCL) for 15,141 shares. E&G Advsrs Limited Partnership has 9,100 shares. Horizon Invest Serv Lc holds 2.31% or 84,385 shares. Old National Bancorp In stated it has 6,061 shares or 0.02% of all its holdings. Estabrook stated it has 0.02% in Carnival Corporation (NYSE:CCL). Fdx Advisors reported 0.21% of its portfolio in Carnival Corporation (NYSE:CCL).

Since January 2, 2018, it had 0 buys, and 20 selling transactions for $10.76 million activity. BAND SIR JONATHON had sold 3,840 shares worth $267,226 on Tuesday, January 16. Shares for $332,073 were sold by DONALD ARNOLD W on Thursday, March 1. The insider Bernstein David sold $299,957. $448,101 worth of stock was sold by PEREZ ARNALDO on Monday, April 16. Another trade for 21,602 shares valued at $1.49 million was made by KRUSE STEIN on Friday, January 12. $288,874 worth of Carnival Corporation (NYSE:CCL) was sold by GLASIER RICHARD.

Among 29 analysts covering Carnival Corporation (NYSE:CCL), 20 have Buy rating, 0 Sell and 9 Hold. Therefore 69% are positive. Carnival Corporation had 79 analyst reports since August 6, 2015 according to SRatingsIntel. SunTrust maintained the stock with “Buy” rating in Thursday, March 31 report. The rating was maintained by Stifel Nicolaus on Thursday, June 22 with “Buy”. The rating was initiated by Deutsche Bank on Thursday, September 29 with “Hold”. The firm has “Equal Weight” rating given on Thursday, December 21 by Barclays Capital. Buckingham Research maintained it with “Buy” rating and $60 target in Wednesday, November 4 report. The stock of Carnival Corporation (NYSE:CCL) has “Buy” rating given on Wednesday, September 23 by Nomura. JP Morgan maintained the shares of CCL in report on Friday, March 23 with “Neutral” rating. The company was maintained on Tuesday, December 19 by J.P. Morgan. The rating was downgraded by Credit Suisse to “Neutral” on Friday, September 15. The firm has “Buy” rating given on Thursday, January 18 by Susquehanna.

Signature Estate & Investment Advisors Llc decreased Ishares (SCZ) stake by 42,238 shares to 84,734 valued at $5.47M in 2017Q4. It also reduced Apple Hospitality Reit Inc stake by 72,692 shares and now owns 104,361 shares. Vanguard World Fds (VFH) was reduced too.

More news for Carnival Corporation (NYSE:CCL) were recently published by: Seekingalpha.com, which released: “Carnvival Corp.: Caribbean Cash Flow King” on May 14, 2018. Seekingalpha.com‘s article titled: “Royal Caribbean: Lower Risk But Also Less Reward” and published on May 15, 2018 is yet another important article.

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company has market cap of $138.57 million. The companyÂ’s specialty pharmaceutical product candidates comprise Epinephrine Injection pre-filled syringe for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of albuterol (APC-2000) and fluticasone (APC-4000) for the treatment of bronchospasm and asthma; and beclomethasone (APC-1000), a metered dose inhaler product for the asthma, as well as APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease. It currently has negative earnings. It also operates a 503B drug outsourcing facility that provides prescription compounded medications to patients, physician clinics, hospitals, surgery centers, and other clients in the United States.

Among 5 analysts covering Adamis Pharma (NASDAQ:ADMP), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Adamis Pharma had 13 analyst reports since December 1, 2015 according to SRatingsIntel. Maxim Group maintained Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) rating on Monday, August 21. Maxim Group has “Buy” rating and $13.0 target. The firm has “Buy” rating given on Monday, May 14 by Maxim Group. FBR Capital maintained Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) on Monday, May 14 with “Buy” rating. B. Riley & Co maintained the shares of ADMP in report on Friday, March 23 with “Buy” rating. The firm earned “Buy” rating on Tuesday, September 12 by Raymond James. Maxim Group maintained Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) rating on Thursday, July 21. Maxim Group has “Buy” rating and $10 target. On Monday, December 4 the stock rating was maintained by Raymond James with “Buy”. As per Tuesday, December 1, the company rating was initiated by Maxim Group. The rating was maintained by Maxim Group with “Buy” on Monday, June 12.

More important recent Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) news were published by: Seekingalpha.com which released: “Adamis Pharmaceuticals: Paging Dr. Carlo” on May 14, 2018, also Seekingalpha.com published article titled: “Adamis Keeps Us Waiting: April Update”, Nasdaq.com published: “Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update” on May 10, 2018. More interesting news about Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) was released by: Nasdaq.com and their article: “Recent Analysis Shows J.Jill, BankUnited, Toronto Dominion Bank, Adamis Pharmaceuticals, BioDelivery Sciences …” with publication date: April 19, 2018.

Carnival Corporation (NYSE:CCL) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *